Fidelity Investments
ENVB icon

Fidelity Investments’s Enveric Biosciences ENVB Stock Holding History

Fidelity Investments’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-286
Closed -$4.76K – 5375
2025
Q1 		$4.76K Buy
+286
New +$9.91K ﹤0.01% 4719
2024
Q3 		– Sell
-1
Closed -$74 – 5554
2024
Q2 		$74 Buy
+1
New +$151 ﹤0.01% 5000
2022
Q4 		– Hold
0
– – – 5408
2022
Q3 		– Hold
0
– – – 4993
2022
Q2 		– Hold
0
– – – 5046
2021
Q3 		– Hold
0
– – – 4516
2021
Q2 		– Hold
0
– – – 4404

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments's ENVB Position: Q2 2025 in Review

Fidelity Investments sold out of Enveric Biosciences (ENVB) in Q2 2025, closing a stake of 286 shares — an estimated $4.76K sold.

Fidelity Investments first reported a position in ENVB in Q2 2024 and held it in 2 quarters. The position peaked at $4.76K in Q1 2025. 10 funds tracked by Wall St. Rank hold ENVB as of Q2 2025.

  • Fidelity Investments reported no remaining Enveric Biosciences position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 286 Enveric Biosciences shares in Q2 2025, an estimated $4.76K.
  • Fidelity Investments first reported a position in Enveric Biosciences in Q2 2024 and held it in 2 quarters.
  • Fidelity Investments's Enveric Biosciences position peaked at $4.76K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.